Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.16 HKD | +2.99% | -1.34% | -24.96% |
Business Summary
Number of employees: 1,089
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development, Manufacturing, Commercialization and Services
100.0
%
| 727 | 100.0 % | 816 | 100.0 % | +12.21% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
91.1
%
| 661 | 90.8 % | 744 | 91.1 % | +12.60% |
Overseas
8.9
%
| 67 | 9.2 % | 72 | 8.9 % | +8.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Xin Fu
DFI | Director of Finance/CFO | 46 | Dec. 17 |
Kevin Gao
COO | Chief Operating Officer | - | - |
Xiang Yang Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Chen Xiang Yang
CTO | Chief Tech/Sci/R&D Officer | 58 | 15-09-30 |
Zhao Renbin
BRD | Director/Board Member | 55 | 15-11-02 |
Norman Kong
PRN | Corporate Officer/Principal | - | - |
Jessie Wang
LAW | General Counsel | - | - |
Xiaodong Jin
PRN | Corporate Officer/Principal | 52 | 20-06-27 |
Manish Tandon
PRN | Corporate Officer/Principal | - | 20-10-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yigong Shi
FOU | Founder | 57 | 15-11-02 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 20-02-29 |
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Lan Hu
BRD | Director/Board Member | 53 | 20-03-10 |
Zhao Renbin
BRD | Director/Board Member | 55 | 15-11-02 |
Dan Dan Dong
BRD | Director/Board Member | 40 | 23-10-10 |
Rong Gang Xie
BRD | Director/Board Member | 39 | 21-03-30 |
Ming Jin
BRD | Director/Board Member | 50 | 22-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 264,648,217 | 0 | 0 | 56.11 % |
Stock B | 1 | 1,497,934,235 | 989,042,031 ( 66.03 %) | 0 |
Company contact information
InnoCare Pharma Ltd.
Building 8, Changping District No. 8 Life Science Park Road
100084, Beijing
+86 10 6660 9999
http://www.innocarepharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.96% | 1.28B | |
+2.93% | 108B | |
-3.46% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- 9969 Stock
- Company InnoCare Pharma Limited